A Study of Onartuzumab (MetMAb) in Combination With Tarceva (Erlotinib) in Participants With Met Diagnostic-Positive Non-Small Cell Lung Cancer Who Have Received Chemotherapy For Advanced or Metastatic Disease (MetLung)
Public ClinicalTrials.gov record NCT01456325. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Phase III, Multicenter, Double-Blind, Placebo-Controlled Study Evaluating Efficacy and Safety of Onartuzumab (Metmab) in Combination With Tarceva (Erlotinib) in Patients With Met Diagnostic-Positive Non-Small Cell Lung Cancer Who Have Received Standard Chemotherapy for Advanced/Metastatic Disease
Study identification
- NCT ID
- NCT01456325
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Genentech, Inc.
- Industry
- Enrollment
- 494 participants
Conditions and interventions
Conditions
Interventions
- Erlotinib Drug
- Onartuzumab (MetMab) Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2011
- Primary completion
- Dec 31, 2015
- Completion
- Dec 31, 2015
- Last update posted
- Nov 1, 2016
2012 – 2016
United States locations
- U.S. sites
- 56
- U.S. states
- 22
- U.S. cities
- 50
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Chandler | Arizona | 85224 | — |
| Not listed | Hayward | California | 94545 | — |
| Not listed | Modesto | California | 95355 | — |
| Not listed | Oakland | California | 94611 | — |
| Not listed | Orange | California | 92868 | — |
| Not listed | Roseville | California | 95661 | — |
| Not listed | Sacramento | California | 95817 | — |
| Not listed | Sacramento | California | 95825 | — |
| Not listed | San Diego | California | 92108 | — |
| Not listed | San Francisco | California | 94115 | — |
| Not listed | San Jose | California | 95119 | — |
| Not listed | Santa Clara | California | 95051 | — |
| Not listed | South San Francisco | California | 94080 | — |
| Not listed | Vallejo | California | 94589 | — |
| Not listed | Walnut Creek | California | 94596 | — |
| Not listed | Boca Raton | Florida | 33486 | — |
| Not listed | Clearwater | Florida | 33761 | — |
| Not listed | Fort Myers | Florida | 33901 | — |
| Not listed | Jacksonville | Florida | 32207 | — |
| Not listed | Jacksonville | Florida | 32256 | — |
| Not listed | Chicago | Illinois | 60637 | — |
| Not listed | Urbana | Illinois | 61801 | — |
| Not listed | Bettendorf | Iowa | 52722 | — |
| Not listed | Sioux City | Iowa | 51101 | — |
| Not listed | Louisville | Kentucky | 40207 | — |
| Not listed | Annapolis | Maryland | 21401 | — |
| Not listed | Baltimore | Maryland | 21201 | — |
| Not listed | Baltimore | Maryland | 21231 | — |
| Not listed | Baltimore | Maryland | 21237 | — |
| Not listed | Boston | Massachusetts | 02114 | — |
| Not listed | Boston | Massachusetts | 02115 | — |
| Not listed | Springfield | Massachusetts | 01107 | — |
| Not listed | Ann Arbor | Michigan | 48106 | — |
| Not listed | Duluth | Minnesota | 55805 | — |
| Not listed | St Louis | Missouri | 63110 | — |
| Not listed | Omaha | Nebraska | 68114 | — |
| Not listed | Reno | Nevada | 89502 | — |
| Not listed | Farmington | New Mexico | 87401 | — |
| Not listed | Syracuse | New York | 13210 | — |
| Not listed | Chapel Hill | North Carolina | 27514 | — |
| Not listed | Canton | Ohio | 44718 | — |
| Not listed | Cleveland | Ohio | 44106 | — |
| Not listed | Columbus | Ohio | 43210 | — |
| Not listed | Columbus | Ohio | 43219 | — |
| Not listed | Philadelphia | Pennsylvania | 19104 | — |
| Not listed | Pittsburgh | Pennsylvania | 15232 | — |
| Not listed | Charleston | South Carolina | 29403 | — |
| Not listed | Columbia | South Carolina | 29210 | — |
| Not listed | Chattanooga | Tennessee | 37404 | — |
| Not listed | Knoxville | Tennessee | 37909 | — |
| Not listed | Nashville | Tennessee | 37203 | — |
| Not listed | Dallas | Texas | 75390 | — |
| Not listed | Fort Worth | Texas | 76104 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | Bristol | Virginia | 24201 | — |
| Not listed | Roanoke | Virginia | 24014 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 157 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01456325, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 1, 2016 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01456325 live on ClinicalTrials.gov.